About the series
Over 3 broadcasts, Jane Diggle and her expert colleagues will discuss GLP-1 Receptor Agonists so you can enhance your knowledge and gain confidence in the practicalities of initiating GLP-1 receptor agonists effectively in daily practice. Also with additional resources.
Included in each programme:
- A one hour webinar including a live Q&A discussion
- Downloadable slides to print off and keep
- A downloadable factsheet summarising the guidance
- A multiple choice question CPD learning module with certificate upon completion
GLP-1 RAs: Translating the theory into practice. An interactive case based discussion
Thursday 1st July, 19.00 hours BST
Host Jane Diggle
Su Down - Case study 1: A case-based discussion covering glucose management
Dr Kevin Fernando Case study 2: A case-based discussion covering initiation of GLP-1 RA for CV benefit
Plus a 30 minute live Q&A session to enable you to pose your questions to the experts.
Your programme presenters
Practice Nurse with Specialist Interest in Diabetes, Ackworth, West Yorkshire
Professor Michael Cummings
Consultant and Honorary Professor in Diabetes and Endocrinology at the Portsmouth
University Hospital NHS Trust (Queen Alexandra Hospital)
Queen’s Nurse, Community Diabetes Specialist Nurse, Manchester University NHS Foundation Trust
Dr Kevin Fernando
GP Partner North Berwick HC, Scottish Lead Primary Care Diabetes Society, Education Director GPnotebook Education
Nurse Consultant Diabetes, Somerset Foundation Trust
If you cannot attend any of the live broadcasts, the webinars will be available on-demand 24 hours after the event.
Understanding the Incretin effect and GLP1 Receptor Agonist Therapy
Wednesday 2nd June, 19.00 hours BST
Host Jane Diggle
Professor Michael Cummings – ‘Understanding the Incretin effect and GLP1 Receptor Agonist Therapy’
- In which conditions do GLP-1 RAs play an important role?
- What are the benefits of GLP-1 RAs on:
- CV benefit & outcome trials
- When is it appropriate to consider GLP-1 RAs and what are the options?
GLP-1 RAs: Practicalities of starting GLP-1 Receptor Agonist Therapy
Wednesday 16th June, 19.00 hours BST
Jane Diggle - ‘The concept of clinical inertia’
- Why is there often a delay in initiating GLP-1 RAs? Clinical inertia, SUNBEAM study
- How do we overcome the barriers and ensure timely introduction?
Nicola Milne - ‘The practicalities of initiating GLP-1 RA therapy’
- The practicalities of starting GLP-1 RA therapy (can it be done remotely)?
- What the person with diabetes needs to know
- Ongoing support and monitoring, including remote management
This educational programme has been sponsored by Eli Lilly and Company
The content, opinions and statements made in this webinar are those of the presenters and do not necessarily reflect the views of the supporters, editors or editorial board and no liability is accepted for the consequences of any misleading or inaccurate information.